FDA Approved: * December 16, 2020 Pharm Company: *TEVA PHARMS USA Category:Antifungal
Efinaconazole, sold under the brand names Jublia and Clenafin, is a triazole antifungal. It is approved for use in the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor.
It was approved as a generic medication in the United States in 2020.[7&a...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions